{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:12:44Z","timestamp":1793502764438,"version":"4.5.0"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC-82003403"],"award-info":[{"award-number":["NSFC-82003403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC-81974077"],"award-info":[{"award-number":["NSFC-81974077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170633"],"award-info":[{"award-number":["82170633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jconrel.2024.10.012","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:52:26Z","timestamp":1729216346000},"page":"318-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis"],"prefix":"10.1016","volume":"376","author":[{"given":"Yue","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.10.012_bb0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molmed.2023.08.001","article-title":"ROS\/RNS as molecular signatures of chronic liver diseases","volume":"29","author":"Che","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0010","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/gutjnl-2021-325065","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFbeta signalling","volume":"71","author":"Hung","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0015","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","article-title":"Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis","volume":"35","author":"Rho","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0020","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000606","article-title":"RNA nanomedicine in liver diseases","author":"Bakrania","year":"2024","journal-title":"Hepatology"},{"issue":"41","key":"10.1016\/j.jconrel.2024.10.012_bb0030","first-page":"e2300666","article-title":"Special Issue: nanotherapeutics in Women\u2019s Health emerging nanotechnologies for triple-negative breast cancer treatment","volume":"20","author":"Torres Quintas","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115073","article-title":"RNAi therapies: expanding applications for extrahepatic diseases and overcoming delivery challenges","volume":"201","author":"Won Lee","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307798120","article-title":"Recent advances in nanoparticulate RNA delivery systems","volume":"121","author":"Witten","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0045","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1158\/1078-0432.CCR-23-2933","article-title":"Infiltrative vessel co-optive growth pattern induced by IQGAP3 overexpression promotes microvascular invasion in hepatocellular carcinoma","volume":"30","author":"Tang","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.actbio.2024.06.014","article-title":"Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis","volume":"184","author":"Qin","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0055","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.7150\/thno.83377","article-title":"Targeting beta-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0060","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1016\/j.apsb.2023.01.009","article-title":"Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0065","first-page":"5195","article-title":"Liver targeting of compound liposomes mediated by glycyrrhetinic acid derivative receptor and its effect on hepatic stellate cells","volume":"48","author":"Wang","year":"2023","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0070","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1021\/acsnano.3c03217","article-title":"Nanoparticle-mediated RNA therapy attenuates nonalcoholic steatohepatitis and related fibrosis by targeting activated hepatic stellate cells","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202307673","article-title":"The material world of 3D-bioprinted and microfluidic-Chip models of human liver fibrosis","volume":"36","author":"Carvalho","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0080","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00109-011-0803-x","article-title":"Genetic variants in candidate genes influencing NAFLD progression","volume":"90","author":"Di Rosa","year":"2012","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00109-009-0464-1","article-title":"Molecular mechanisms involved in NAFLD progression","volume":"87","author":"Malaguarnera","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0100","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0105","first-page":"1","article-title":"Dysfunction of autophagy in high-fat diet-induced nonalcoholic fatty liver disease","author":"Ren","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41575-023-00832-w","article-title":"Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis","volume":"20","author":"Sharma","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0115","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0120","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0130","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189086","article-title":"Abnormal metabolism in hepatic stellate cells: Pandora\u2019s box of MAFLD related hepatocellular carcinoma","volume":"1879","author":"Sun","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0140","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","article-title":"Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease","volume":"77","author":"Mitten","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0145","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122547","article-title":"The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: a concise review","volume":"344","author":"Kim","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0170","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/hep.30766","article-title":"Dysregulated autophagy and lysosome function are linked to exosome production by Micro-RNA 155 in alcoholic liver disease","volume":"70","author":"Babuta","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.831004","article-title":"Cell-to-cell Communications in Alcohol-Associated Liver Disease","volume":"13","author":"Osna","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0180","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122318","article-title":"Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers","volume":"302","author":"Balaji","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0190","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats","volume":"142","author":"Xie","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0195","doi-asserted-by":"crossref","first-page":"4097205","DOI":"10.1155\/2017\/4097205","article-title":"SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis","volume":"2017","author":"Natarajan","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","article-title":"Angiocrine signaling in sinusoidal homeostasis and liver diseases","volume":"81","author":"Gao","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0210","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00204-016-1814-8","article-title":"Adverse outcome pathway development from protein alkylation to liver fibrosis","volume":"91","author":"Horvat","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2018.10.015","article-title":"Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury","volume":"70","author":"Ruart","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0220","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0230","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/gutjnl-2023-331785","article-title":"Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?","volume":"73","author":"Breitkopf-Heinlein","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0235","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.2147\/IJN.S123437","article-title":"Nanomedicine applications in the treatment of breast cancer: current state of the art","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0240","article-title":"Insights on drug and gene delivery systems in liver fibrosis","volume":"18","author":"Vyas","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411869","article-title":"Liver cell type-specific targeting by Nanoformulations for therapeutic applications","volume":"24","author":"Kaps","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303713","article-title":"Novel vectors and administrations for mRNA delivery","volume":"19","author":"Bai","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/wnan.1304","article-title":"Pharmacokinetics of metallic nanoparticles","volume":"7","author":"Lin","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0260","doi-asserted-by":"crossref","first-page":"31938","DOI":"10.1021\/acsami.8b10527","article-title":"Inorganic nanomaterials as highly efficient inhibitors of cellular hepatic fibrosis","volume":"10","author":"Peng","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010035","article-title":"Titanium dioxide nanoparticles enhance leakiness and drug permeability in primary human hepatic sinusoidal endothelial cells","volume":"20","author":"Tee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2018.12.003","article-title":"Effects of inorganic nanoparticles on liver fibrosis: optimizing a double-edged sword for therapeutics","volume":"160","author":"Tee","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0275","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1039\/D0TB01021A","article-title":"MOF-derived novel porous Fe(3)O(4)@C nanocomposites as smart nanomedical platforms for combined cancer therapy: magnetic-triggered synergistic hyperthermia and chemotherapy","volume":"8","author":"Xiang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0280","doi-asserted-by":"crossref","first-page":"13698","DOI":"10.1021\/acsami.0c01666","article-title":"Metal-organic framework\/ag-based hybrid Nanoagents for rapid and synergistic bacterial eradication","volume":"12","author":"Yang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/thno.37301","article-title":"Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105467","article-title":"Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: a biocompatible pH-responsive nanocarrier for gemcitabine release on MCF-7 human breast cancer cells","volume":"118","author":"Abd Al-Jabbar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111788","article-title":"A protein-sulfosalicylic acid\/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system","volume":"204","author":"Ozsoy","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123167","article-title":"Vitamin A-modified ZIF-8 lipid nanoparticles for the therapy of liver fibrosis","volume":"642","author":"Qin","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113567","article-title":"Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy","volume":"231","author":"Wang","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0310","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s43630-023-00396-3","article-title":"Effect of carbon quantum dots derived from extracts of UV-B-exposed Eclipta alba on alcohol-induced liver cirrhosis in Golden Hamster","volume":"22","author":"Rai","year":"2023","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0315","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1021\/acs.nanolett.4c00955","article-title":"Identification of early stage liver fibrosis by modifications in the interstitial space diffusive microenvironment using fluorescent single-walled carbon nanotubes","volume":"24","author":"Lee","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0320","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1039\/D3BM01710A","article-title":"Antifibrotic activity of carbon quantum dots in a human in vitro model of non-alcoholic steatohepatitis using hepatic stellate cells","volume":"12","author":"Garcia-Topete","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0325","doi-asserted-by":"crossref","first-page":"33021","DOI":"10.1021\/acsami.4c04361","article-title":"Aggregation-induced emission CN-based nanoparticles to alleviate hypoxic liver fibrosis via triggering HSC Ferroptosis and enhancing photodynamic therapy","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081271","article-title":"Hybrid Material Based on Vaccinium myrtillus L. Extract and Gold Nanoparticles Reduces Oxidative Stress and Inflammation in Hepatic Stellate Cells Exposed to TGF-beta","volume":"13","author":"Filip","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0335","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ajps.2017.04.001","article-title":"Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats","volume":"12","author":"Krishnan","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.06.008","article-title":"Spherical neutral gold nanoparticles improve anti-inflammatory response, oxidative stress and fibrosis in alcohol-methamphetamine-induced liver injury in rats","volume":"548","author":"de Carvalho","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0345","doi-asserted-by":"crossref","first-page":"18403","DOI":"10.1038\/s41598-022-23276-9","article-title":"Anti-liver fibrosis activity of curcumin\/chitosan-coated green silver nanoparticles","volume":"12","author":"Elzoheiry","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0350","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/acs.analchem.1c04448","article-title":"Aptamer-assisted protein orientation on silver magnetic nanoparticles: application to sensitive leukocyte cell-derived Chemotaxin 2 surface Plasmon resonance sensors","volume":"94","author":"Zhu","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0355","doi-asserted-by":"crossref","first-page":"26308","DOI":"10.1007\/s11356-022-23876-y","article-title":"Silver nanoparticles induced testicular damage targeting NQO1 and APE1 dysregulation, apoptosis via Bax\/Bcl-2 pathway, fibrosis via TGF-beta\/alpha-SMA upregulation in rats","volume":"30","author":"Assar","year":"2023","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0360","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jconrel.2020.09.041","article-title":"Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo","volume":"328","author":"Kurniawan","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0365","first-page":"406","article-title":"Engineered SPIONs functionalized with endothelin a receptor antagonist ameliorate liver fibrosis by inhibiting hepatic stellate cell activation","volume":"39","author":"Ten Hove","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0370","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1039\/D0RA09589C","article-title":"Mitochondria-targeted curcumin loaded CTPP-PEG-PCL self-assembled micelles for improving liver fibrosis therapy","volume":"11","author":"Zhang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0375","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1039\/D3TB02766J","article-title":"Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders","volume":"12","author":"Chu","year":"2024","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115359","article-title":"Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: clinical applications","volume":"211","author":"Masarwy","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0385","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.addr.2021.04.003","article-title":"Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis","volume":"173","author":"Salunkhe","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-024-01574-1","article-title":"Lipid-based nanosystems: the next generation of cancer immune therapy","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0395","article-title":"An autologous macrophage-based phenotypic transformation-collagen degradation system treating advanced liver fibrosis","volume":"11","author":"Duan","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122049","article-title":"Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice","volume":"295","author":"Kumar","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0405","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0410","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0420","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular Corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0425","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","article-title":"Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: a novel strategy with potent efficacy in experimental liver fibrosis","volume":"266","author":"El-Mezayen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0430","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1039\/D2RA07561J","article-title":"Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis","volume":"13","author":"Xiong","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0435","article-title":"Smart Microneedle Arrays Integrating Cell-Free Therapy and Nanocatalysis to Treat Liver Fibrosis","volume":"11","author":"Xu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0440","first-page":"112","article-title":"Stem cell-derived hepatocyte therapy using versatile biomimetic nanozyme incorporated nanofiber-reinforced decellularized extracellular matrix hydrogels for the treatment of acute liver failure","volume":"28","author":"Jin","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0445","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.7150\/thno.22806","article-title":"Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer (99m)Tc-GlcNAc-PEI for liver fibrosis imaging with SPECT","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0450","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0455","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molmed.2019.02.003","article-title":"Immune cell-derived extracellular vesicles - functions and therapeutic applications","volume":"25","author":"Veerman","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0460","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0465","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.32239","article-title":"Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space","volume":"76","author":"Devaraj","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0470","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/hep.32662","article-title":"Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis","volume":"77","author":"Liu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0475","first-page":"126","article-title":"Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade","volume":"36","author":"Moghassemi","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0480","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.7150\/thno.93115","article-title":"Extracellular vesicles as carriers of mRNA: opportunities and challenges in diagnosis and treatment","volume":"14","author":"Kirian","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9435","article-title":"Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases","volume":"8","author":"Wan","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0490","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1039\/D4BM00054D","article-title":"Functionalized extracellular nanovesicles as advanced CRISPR delivery systems","volume":"12","author":"Wang","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0495","doi-asserted-by":"crossref","first-page":"29737","DOI":"10.1021\/acsami.4c03213","article-title":"Cell-specific impacts of surface coating composition on extracellular vesicle secretion","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12343","article-title":"Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing","volume":"12","author":"Whitley","year":"2023","journal-title":"J. Extrac. Vesicl."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0505","article-title":"Creating designer engineered extracellular vesicles for diverse ligand display, target recognition, and controlled protein loading and delivery","volume":"10","author":"Ivanova","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0510","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1021\/acsami.3c18029","article-title":"Orally deliverable sequence-targeted Fucoxanthin-loaded biomimetic extracellular vesicles for alleviation of nonalcoholic fatty liver disease","volume":"16","author":"Wu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0515","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2021.06.031","article-title":"Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo","volume":"336","author":"You","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0520","article-title":"Two-membrane hybrid Nanobiomimetic delivery system for targeted autophagy inhibition of activated hepatic stellate cells to synergistically treat liver fibrosis","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0525","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/IJN.S450284","article-title":"BMP7-loaded human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate liver fibrosis by targeting activated hepatic stellate cells","volume":"19","author":"Zhu","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0530","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0535","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116143","article-title":"Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats","volume":"171","author":"Perramon","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0545","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.actbio.2023.08.022","article-title":"Targeted heart repair by Tbeta4-loaded cardiac-resident macrophage-derived extracellular vesicles modified with monocyte membranes","volume":"169","author":"Chen","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0550","doi-asserted-by":"crossref","first-page":"20653","DOI":"10.1021\/jacs.2c07657","article-title":"Rapid biotransformation of luminescent bimetallic nanoparticles in hepatic sinusoids","volume":"144","author":"Tan","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121492","article-title":"Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis","volume":"284","author":"Wu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0560","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jconrel.2024.07.039","article-title":"A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy","volume":"373","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0565","article-title":"SHISA3 reprograms tumor-associated macrophages toward an antitumoral phenotype and enhances cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0570","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122310119","article-title":"pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages","volume":"119","author":"Kaps","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0575","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","article-title":"Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis","volume":"343","author":"Zhou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0580","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1021\/acs.nanolett.8b02498","article-title":"Graphene-dendrimer Nanostars for targeted macrophage overexpression of metalloproteinase 9 and hepatic fibrosis precision therapy","volume":"18","author":"Melgar-Lesmes","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0585","doi-asserted-by":"crossref","first-page":"24071","DOI":"10.1021\/acsami.3c01047","article-title":"Engineered biomimetic copper sulfide Nanozyme mediates \u201cDon\u2019t eat me\u201d signaling for Photothermal and Chemodynamic precision therapies of breast Cancer","volume":"15","author":"Zhan","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0590","article-title":"Inflammation-responsive cell membrane-camouflaged nanoparticles against liver fibrosis via regulating endoplasmic reticulum stress and oxidative stress","volume":"36","author":"Bai","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0595","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1021\/acs.molpharmaceut.4c00249","article-title":"Liver fibrosis amelioration by macrophage-biomimetic Polydopamine nanoparticles via synergistically alleviating inflammation and scavenging ROS","volume":"21","author":"Ma","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0600","doi-asserted-by":"crossref","first-page":"14029","DOI":"10.1021\/acsnano.2c03858","article-title":"Sequential Nano-penetrators of Capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0605","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00292-020-00802-y","article-title":"Liver sinusoids: pathology of endothelial findings","volume":"41","author":"Goltz","year":"2020","journal-title":"Pathologe"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0615","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102463","article-title":"Optimization of statin-loaded delivery nanoparticles for treating chronic liver diseases by targeting liver sinusoidal endothelial cells","volume":"15","author":"Gil","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0625","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.02.022","article-title":"Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis","volume":"368","author":"Wang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0630","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0635","article-title":"Restoration of sinusoid fenestrae followed by targeted Nanoassembly delivery of an anti-fibrotic agent improves treatment efficacy in liver fibrosis","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0640","doi-asserted-by":"crossref","first-page":"eabq6225","DOI":"10.1126\/scitranslmed.abq6225","article-title":"RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0645","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1039\/D1BM01663F","article-title":"Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity","volume":"10","author":"Ji","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081905","article-title":"In vivo siRNA delivery to immunosuppressive liver macrophages by alpha-Mannosyl-functionalized cationic Nanohydrogel particles","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0655","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2018.09.004","article-title":"Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis","volume":"288","author":"Kurniawan","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12951-021-01205-8","article-title":"Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma","volume":"20","author":"Yu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0665","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002694R","article-title":"miR-30c inhibits angiogenesis by targeting delta-like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis","volume":"35","author":"Gu","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0670","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1021\/acs.molpharmaceut.4c00173","article-title":"Neutrophil-based bionic delivery system breaks through the capillary barrier of liver sinusoidal endothelial cells and inhibits the activation of hepatic stellate cells","volume":"21","author":"Sun","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0675","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"Bottcher","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0680","doi-asserted-by":"crossref","first-page":"E1142","DOI":"10.1073\/pnas.1521265113","article-title":"Tailoring nanoparticle designs to target cancer based on tumor pathophysiology","volume":"113","author":"Sykes","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0685","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.19.00056","article-title":"Targeting stroma: a tale of caution","volume":"37","author":"Wang-Gillam","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0690","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1021\/acsnano.9b02395","article-title":"Collagenase nanoparticles enhance the penetration of drugs into pancreatic tumors","volume":"13","author":"Zinger","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0695","article-title":"A size-changeable collagenase-modified Nanoscavenger for increasing penetration and retention of nanomedicine in deep tumor tissue","volume":"32","author":"Xu","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119616","article-title":"Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy","volume":"230","author":"Fan","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0705","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2022.08.065","article-title":"Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy","volume":"152","author":"Zhou","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0710","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.actbio.2023.12.027","article-title":"Collagenase type I and Probucol-loaded nanoparticles penetrate the extracellular matrix to target hepatic stellate cells for hepatic fibrosis therapy","volume":"175","author":"Wang","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0715","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2023.05.002","article-title":"Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosis","volume":"358","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0720","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clinimag.2012.02.017","article-title":"Attenuation of hepatic fibrosis through ultrasound-microbubble-mediated HGF gene transfer in rats","volume":"37","author":"Jiang","year":"2013","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0725","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2017.02.004","article-title":"Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis","volume":"7","author":"Huang","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0735","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13287-020-01655-1","article-title":"Ultrasound-targeted microbubble destruction optimized HGF-overexpressing bone marrow stem cells to repair fibrotic liver in rats","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0740","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.addr.2021.02.015","article-title":"Opening doors with ultrasound and microbubbles: beating biological barriers to promote drug delivery","volume":"172","author":"Deprez","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0745","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.118.256156","article-title":"Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis","volume":"370","author":"Chen","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106189","article-title":"Vitamin a - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection","volume":"174","author":"Liu","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0755","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0760","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2018.11.018","article-title":"Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis","volume":"134","author":"Hassan","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0765","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2012.08.008","article-title":"Exosomes for targeted siRNA delivery across biological barriers","volume":"65","author":"El Andaloussi","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0770","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0775","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0780","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.xphs.2017.04.042","article-title":"The delivery of small interfering RNA to hepatic stellate cells using a lipid nanoparticle composed of a vitamin A-scaffold lipid-like material","volume":"106","author":"Toriyabe","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0785","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jconrel.2020.02.049","article-title":"Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis","volume":"321","author":"Qiao","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0790","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3892\/mmr.2015.3842","article-title":"Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0795","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0800","first-page":"739A","article-title":"Safety, pharmacokinetics, and immunogenicity of BMS-986263\/ND-L02-s0201 in healthy Japanese and non-Japanese participants, hepatology, WILEY 111 RIVER ST, HOBOKEN 07030-5774","author":"Soule","year":"2018","journal-title":"NJ USA"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0805","first-page":"S242","article-title":"Clinical phase 1b study results for safety, pharmacokinetics and efficacy of ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 SIRNA for the treatment of Japanese patients with advanced liver fibrosis","volume":"68","author":"Sakamoto","year":"2018"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0810","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/jcmm.16209","article-title":"Hepatic stellate cells specific liposomes with the toll-like receptor 4 shRNA attenuates liver fibrosis","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0815","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","article-title":"Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1alpha transcriptional complex","volume":"79","author":"Wang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0820","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000299","article-title":"HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis","volume":"7","author":"Huang","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0825","doi-asserted-by":"crossref","first-page":"1801809","DOI":"10.1002\/advs.201801809","article-title":"Synergistic MicroRNA therapy in liver fibrotic rat using MRI-visible Nanocarrier targeting hepatic stellate cells","volume":"6","author":"Wu","year":"2019","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0830","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","article-title":"Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis","volume":"76","author":"Kumar","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0835","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.ymthe.2018.08.022","article-title":"Therapeutic potential of OMe-PS-miR-29b1 for treating liver fibrosis","volume":"26","author":"Kumar","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0840","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hepr.13040","article-title":"Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis","volume":"48","author":"Furuhashi","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0845","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/hepr.13317","article-title":"Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects","volume":"49","author":"Okimoto","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0850","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.16156","article-title":"Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation of glutaminase 1","volume":"180","author":"Chen","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0855","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/hum.2012.158","article-title":"Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis","volume":"24","author":"Narmada","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0860","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/liv.15915","article-title":"Targeted inhibition of autophagy in hepatic stellate cells by hydroxychloroquine: An effective therapeutic approach for the treatment of liver fibrosis","volume":"44","author":"Hou","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0865","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.actbio.2023.07.035","article-title":"Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles","volume":"168","author":"Xiang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0870","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2018.05.021","article-title":"Oral vitamin-A-coupled valsartan nanomedicine: high hepatic stellate cell receptors accessibility and prolonged enterohepatic residence","volume":"283","author":"El-Mezayen","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0875","doi-asserted-by":"crossref","first-page":"23608","DOI":"10.1021\/acsnano.3c06626","article-title":"Hepatic stellate cell- and liver microbiome-specific delivery system for Dihydrotanshinone I to ameliorate liver fibrosis","volume":"17","author":"Niu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0880","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.2147\/IJN.S270242","article-title":"Zein\/phospholipid composite nanoparticles for successful delivery of Gallic acid into aHSCs: influence of size, surface charge, and vitamin a coupling","volume":"15","author":"Radwan","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122063","article-title":"Synthesis and preparation of vitamin a coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats","volume":"625","author":"Mahdinloo","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0890","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jhep.2020.04.044","article-title":"Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis","volume":"73","author":"Gao","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0895","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0900","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/mp700118p","article-title":"PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells","volume":"5","author":"Schoemaker","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0905","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Bansal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0915","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.2174\/1381612822666161208144953","article-title":"Long-circulating liposomal delivery system targeting at PDGFR-beta enhances the therapeutic effect of IFN-alpha on hepatic fibrosis","volume":"23","author":"Li","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0920","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/acs.molpharmaceut.7b00709","article-title":"pPB peptide-mediated siRNA-loaded stable nucleic acid lipid nanoparticles on targeting therapy of hepatic fibrosis","volume":"15","author":"Jia","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0925","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jcmm.14097","article-title":"Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0930","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual Antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0935","doi-asserted-by":"crossref","first-page":"15220","DOI":"10.1002\/anie.202101033","article-title":"Hydrogen atom transfer from HOO(.) to ortho-Quinones explains the antioxidant activity of Polydopamine","volume":"60","author":"Guo","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122028","article-title":"Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment","volume":"295","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0945","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11307-012-0578-7","article-title":"Peptide-based targeting of the platelet-derived growth factor receptor beta","volume":"15","author":"Askoxylakis","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060590","article-title":"Targeting activated hepatic stellate cells using collagen-Binding chitosan nanoparticles for siRNA delivery to fibrotic livers","volume":"12","author":"Azzam","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0955","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2407-11-290","article-title":"The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7","volume":"11","author":"Fang","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0960","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1021\/acsbiomaterials.3c00327","article-title":"Drug delivery with hyaluronic acid-coated polymeric micelles in liver fibrosis therapy","volume":"9","author":"Yoshizaki","year":"2023","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0965","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14010011","article-title":"Ameliorative effect of curcumin-encapsulated hyaluronic acid-PLA nanoparticles on Thioacetamide-induced murine hepatic fibrosis","volume":"14","author":"Chen","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0970","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1039\/D1BM01499D","article-title":"Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex","volume":"9","author":"Ren","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0975","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid-bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106783","article-title":"Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis","volume":"198","author":"Yu","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0985","article-title":"Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb0990","doi-asserted-by":"crossref","first-page":"45110","DOI":"10.1021\/acsami.2c10446","article-title":"Therapeutic response of multifunctional lipid and micelle formulation in hepatocellular carcinoma","volume":"14","author":"Wu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb0995","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2147\/IJN.S366180","article-title":"GA&HA-modified liposomes for co-delivery of Aprepitant and curcumin to inhibit drug-resistance and metastasis of hepatocellular carcinoma","volume":"17","author":"Li","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1000","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s12274-020-2833-6","article-title":"Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis","volume":"13","author":"Liang","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","article-title":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1010","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.13029","article-title":"A pH-responsive hyaluronic acid nano-vehicle co-encapsulating doxorubicin and all-trans retinoic acid for the inhibition of hepatic stellate cell-induced tumor growth and metastasis","volume":"28","author":"Lu","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117964","article-title":"Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1020","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1021\/acsnano.8b06924","article-title":"Golgi apparatus-targeted chondroitin-modified Nanomicelles suppress hepatic stellate cell activation for the management of liver fibrosis","volume":"13","author":"Luo","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122232","article-title":"Dually fibronectin\/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis","volume":"301","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1030","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1021\/acsami.3c17670","article-title":"Dual-targeting macrophages and hepatic stellate cells by modified albumin nanoparticles for liver cirrhosis treatment","volume":"16","author":"Tan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1035","doi-asserted-by":"crossref","first-page":"28941","DOI":"10.1021\/acsami.3c03416","article-title":"Autophagy-interfering Nanoboat drifting along CD44-Golgi-ER flow as RNAi therapeutics for hepatic fibrosis","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1040","article-title":"Vicious cycle-breaking lipid nanoparticles remodeling multicellular crosstalk to reverse liver fibrosis","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1045","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1050","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1055","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v18.i31.4199","article-title":"Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells","volume":"18","author":"Chai","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111342","article-title":"Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis","volume":"137","author":"Peng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1065","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1039\/C7RA10847H","article-title":"The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles","volume":"8","author":"Li","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0167-4838(95)00026-Q","article-title":"Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen","volume":"1249","author":"Marcelino","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg-Gly-asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2008.07.021","article-title":"Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis","volume":"131","author":"Li","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","article-title":"Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats","volume":"52","author":"Yang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1090","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/acsami.3c12776","article-title":"Integrin-targeted Theranostic nanoparticles for clinical MRI-traceable treatment of liver fibrosis","volume":"16","author":"Hu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1095","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3892\/mmr.2016.5673","article-title":"Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.actbio.2023.06.032","article-title":"CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis","volume":"168","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1110","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1021\/ja102635c","article-title":"Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands","volume":"132","author":"Nakagawa","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1115","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-019-10893-8","article-title":"Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy","volume":"10","author":"Hu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1120","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1021\/acsnano.6b02776","article-title":"The Binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors","volume":"10","author":"Miao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2016.01.021","article-title":"Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles","volume":"224","author":"Dasargyri","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41565-020-00836-6","article-title":"Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis","volume":"16","author":"Hu","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jhep.2012.03.026","article-title":"M6P\/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues","volume":"57","author":"Puxbaum","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10611860601141481","article-title":"Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes","volume":"15","author":"Adrian","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2018.10.003","article-title":"Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers","volume":"552","author":"Morsy","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1155","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/acs.molpharmaceut.5b00177","article-title":"Discovery of peptide ligands for hepatic stellate cells using phage display","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1160","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030448","article-title":"Peptide-based siRNA Nanocomplexes targeting hepatic stellate cells","volume":"13","author":"Lin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1165","first-page":"651","article-title":"Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts","volume":"151","author":"Blazejewski","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00428-002-0631-z","article-title":"Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis","volume":"441","author":"Nakatani","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1175","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/jhep.2000.9322","article-title":"Proteome analysis of rat hepatic stellate cells","volume":"32","author":"Kristensen","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","article-title":"Nab-paclitaxel mechanisms of action and delivery","volume":"170","author":"Yardley","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118940","article-title":"Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways","volume":"574","author":"Wang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1190","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.nanolett.3c03689","article-title":"Senescence of hepatic stellate cells by specific delivery of manganese for limiting liver fibrosis","volume":"24","author":"Gu","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1195","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1021\/acsami.2c19269","article-title":"Albumin-based Silibinin nanocrystals targeting activated hepatic stellate cells for liver fibrosis therapy","volume":"15","author":"Luo","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1200","doi-asserted-by":"crossref","first-page":"38968","DOI":"10.1021\/acsami.4c06034","article-title":"Albumin-based MUC13 peptide nanomedicine suppresses liver Cancer stem cells via JNK-ERK signaling pathway-mediated autophagy inhibition","volume":"16","author":"Sun","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1205","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10495-024-01995-w","article-title":"Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2005.08.027","article-title":"Interaction of targeted liposomes with primary cultured hepatic stellate cells: involvement of multiple receptor systems","volume":"44","author":"Adrian","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2019.04.022","article-title":"An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis","volume":"303","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1220","article-title":"Mitochondria-regulated information processing nanosystem promoting immune cell communication for liver fibrosis regression","volume":"20","author":"Che","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1225","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1021\/acs.molpharmaceut.6b01174","article-title":"Highly selective targeting of hepatic stellate cells for liver fibrosis treatment using a d-enantiomeric peptide ligand of Fn14 identified by Mirror-image mRNA display","volume":"14","author":"Huang","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1230","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12951-022-01311-1","article-title":"A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion","volume":"20","author":"Guo","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1235","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2217\/nnm-2019-0302","article-title":"New FH peptide-modified ultrasonic nanobubbles for delivery of doxorubicin to cancer-associated fibroblasts","volume":"14","author":"Guo","year":"2019","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1240","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12951-022-01636-x","article-title":"Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy","volume":"20","author":"Lin","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1245","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-022-29186-8","article-title":"Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2023.01.052","article-title":"Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells","volume":"355","author":"Xia","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1255","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/acsami.2c16616","article-title":"Folate decoration supports the targeting of Camptothecin micelles against activated hepatic stellate cells and the suppression of Fibrogenesis","volume":"15","author":"Xiang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1021\/acsptsci.3c00087","article-title":"Delivery of Oleanolic acid with improved Antifibrosis efficacy by a cell penetrating peptide P10","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1265","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/IJN.S171280","article-title":"CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFbeta-induced HSC-T6 cells activation","volume":"14","author":"Ullah","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1270","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7150\/thno.21168","article-title":"Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development","volume":"8","author":"Sung","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1275","article-title":"Hepatic stellate cell-targeting micelle nanomedicine for early diagnosis and treatment of liver fibrosis","volume":"13","author":"Wang","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111015","article-title":"Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells","volume":"395","author":"Zhang","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1285","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2022.12.020","article-title":"Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis","volume":"353","author":"Younis","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1290","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1038\/ncomms11675","article-title":"Rational design of a protein that binds integrin alphavbeta3 outside the ligand binding site","volume":"7","author":"Turaga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1295","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1300","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1305","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jconrel.2023.08.021","article-title":"Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice","volume":"361","author":"Younis","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137447","article-title":"Depletion of activated hepatic stellate cells and Capillarized liver sinusoidal endothelial cells using a rationally designed protein for nonalcoholic steatohepatitis and alcoholic hepatitis treatment","volume":"25","author":"Mishra","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2016.06.012","article-title":"Nanomedicine of synergistic drug combinations for cancer therapy - strategies and perspectives","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jconrel.2024.04.050","article-title":"Metabolic dysfunction-associated steatohepatitis treated by poly(ethylene glycol)-block-poly(cysteine) block copolymer-based self-assembling antioxidant nanoparticles","volume":"370","author":"Koda","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1325","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305830","article-title":"Longitudinal magnetic resonance imaging with ROS-responsive bilirubin nanoparticles enables monitoring of nonalcoholic steatohepatitis progression to cirrhosis","volume":"36","author":"Jung","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1330","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202406758","article-title":"Reactive oxygen species responsive multifunctional fusion extracellular nanovesicles: prospective treatments for acute heart transplant rejection","volume":"36","author":"Lu","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122403","article-title":"Reactive oxygen species responsive chitooligosaccharides based nanoplatform for sonodynamic therapy in mammary cancer","volume":"342","author":"Sun","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12951-024-02685-0","article-title":"Targeted delivery of black phosphorus nanosheets by ROS responsive complex hydrogel based on angiogenesis and antioxidant promotes myocardial infarction repair","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.012_bb1345","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306394","article-title":"Nanoparticle assembly: from self-organization to controlled micropatterning for enhanced functionalities","volume":"20","author":"Jambhulkar","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.10.012_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115042","article-title":"Engineering nanoparticle toolkits for mRNA delivery","volume":"200","author":"Sun","year":"2023","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T08:36:03Z","timestamp":1733560563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924006758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":270,"alternative-id":["S0168365924006758"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}